Association Between Central Obesity and Membranous Nephropathy

12 July 2025 : Clinical Research

Daoyuan Lv^{BCDEFG 1,2}, Laping Chu^{BCDF 1,2}, Yuan Du^{BCDF 1,2}, Hongwei Jiang^{BCD 1,2}, Xilian Zhou^{BCD 1,2}, Yafen Yu^{AG 1,2*}

DOI: 10.12659/MSM.947570

Med Sci Monit 2025; 31:e947570

Authors information Article notes Copyright and License information

Introduction Material and Methods Results Discussion Conclusions References

Related articles Order reprints Share article Share by email

View HTML version

Table 2 Pathological phenotypes of the enrolled patients.

	All patients (n=255)	Non-central obesity patients (n=201)	Central obesity patients (n=54)	p
IgG deposits	3.227±0.528	3.214±0.519	3.278±0.564	0.431
IgA deposits	0.239±0.526	0.209±0.486	0.352±0.649	0.136
IgM deposits	0.133±0.374	0.124±0.373	0.167±0.376	0.461
C1q deposits	0.325±0.525	0.308±0.514	0.389±0.564	0.318
C3 deposits	2.584±0.874	2.572±0.858	2.630±0.938	0.669
Glomerular sclerosis (%)	7.358±12.169	6.961±11.951	8.832±12.958	0.317
Podocyte foot process width (nm)	2213.560±896.351	2080.795±864.782	2707.740±844.237	<0.001

Back to the Article